SMARCB1 Negative
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT03587662) | M.D. Anderson Cancer Center | 2018-08-17 |
Track SMARCB1 Negative automatically
Every clearance here is in the API, with alerts when new ones post.